Viewing Study NCT01169012

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2026-03-13 @ 12:02 AM
Study NCT ID: NCT01169012
Status: COMPLETED
Last Update Posted: 2017-08-22
First Post: 2010-07-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome View
None Acute Myeloid Leukemia View
None Acute Lymphoblastic Leukemia View
None Chronic Myelomonocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myelodysplastic syndrome View
None Acute Myeloid Leukemia View
None Acute Lymphoblastic Leukemia View
None Chronic myelomonocytic leukemia View
None Clofarabine View
None Clolar View
None University of North Carolina at Chapel Hill View
None Lineberger Comprehensive Cancer Center View